Ferroptosis: New Dawn for Overcoming the Cardio-Cerebrovascular Diseases

Meng-Yi Luo1,2, Jian-Hui Su1,2, Shao-Xin Gong3

  • 1Institute of Clinical Research, Affiliated Nanhua Hospital, University of South China, Hengyang, China.

Insights

Ferroptosis, a cell death form, is crucial in heart and brain diseases. Inhibitors targeting ferroptosis offer potential treatments for cardio-cerebrovascular conditions like stroke and heart attack.

Area of Science:

  • Cardiovascular Biology
  • Neuroscience
  • Cell Death Mechanisms

Background:

  • Cardiomyocyte and neuron survival is vital for heart and brain function.
  • Imbalances in cell death contribute to cardio-cerebrovascular diseases (CCVDs) such as hypertension, myocardial infarction, and ischemic stroke.
  • Ferroptosis, a newly identified iron-dependent cell death, is implicated in various pathologies.

Purpose of the Study:

  • To review the critical role of ferroptosis in CCVDs.
  • To explore the regulatory mechanisms of ferroptosis in the context of CCVDs.
  • To discuss the therapeutic potential of ferroptosis inhibitors for CCVDs.

Main Methods:

  • Literature review focusing on ferroptosis and CCVDs.
  • Analysis of regulatory pathways of ferroptosis.
  • Evaluation of ferroptosis inhibitors' functions.

Main Results:

  • Ferroptosis is a significant contributor to the pathogenesis of CCVDs.
  • Specific molecular mechanisms regulate ferroptosis in cardiac and neural tissues.
  • Ferroptosis inhibitors demonstrate promising effects in preclinical models.

Conclusions:

  • Ferroptosis plays a key role in the development and progression of CCVDs.
  • Understanding ferroptosis regulation is essential for developing targeted therapies.
  • Ferroptosis inhibitors represent a potential therapeutic strategy for preventing and treating CCVDs.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.0K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.0K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
376
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
390
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
78